BEUT Stock Overview
Science to Consumers, Inc., a development stage company, focuses on marketing and selling formulated anti-aging cream products under the DermaLastyl name; and distributing Argan oil products.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Science to Consumers, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0003 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -100.00% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
BEUT | US Retail Distributors | US Market | |
---|---|---|---|
7D | 0% | 2.1% | -3.7% |
1Y | n/a | -2.5% | 20.2% |
Return vs Industry: Insufficient data to determine how BEUT performed against the US Retail Distributors industry.
Return vs Market: Insufficient data to determine how BEUT performed against the US Market.
Price Volatility
BEUT volatility | |
---|---|
BEUT Average Weekly Movement | n/a |
Retail Distributors Industry Average Movement | 12.1% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BEUT has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BEUT's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | n/a | Ensley Lam | n/a |
Science to Consumers, Inc., a development stage company, focuses on marketing and selling formulated anti-aging cream products under the DermaLastyl name; and distributing Argan oil products. It intends to sell its products to individual customers and commercial customers, such as spas, stores, and massage therapy offices. The company was formerly known as Argan Beauty Corporation and changed its name to Science to Consumers, Inc. in December 2014.
Science to Consumers, Inc. Fundamentals Summary
BEUT fundamental statistics | |
---|---|
Market cap | US$31.00 |
Earnings (TTM) | -US$69.33k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs BEUT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BEUT income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$69.33k |
Earnings | -US$69.33k |
Last Reported Earnings
Feb 28, 2017
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did BEUT perform over the long term?
See historical performance and comparison